Clinical characteristics do not reliably identify non-adherence in patients with uncontrolled hypertension

References

• Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–450.
   PubMed Web of Science ®Google Scholar
• Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet (London, England. 2012;380(9859):2095–2128.
   PubMed Web of Science ®Google Scholar
• Mazzaglia G, Ambrosioni E, Alacqua M, et al. Adherence to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients. Circulation. 2009;120(16):1598–1605.
   PubMed Web of Science ®Google Scholar
• Sokol MC, McGuigan KA, Verbrugge RR, et al. Impact of medication adherence on hospitalization risk and healthcare cost. Med Care. 2005;43(6):521–530.
   PubMed Web of Science ®Google Scholar
• Hamdidouche I, Jullien V, Boutouyrie P, et al. Drug adherence in hypertension: from methodological issues to cardiovascular outcomes. J Hypertens. 2017;35(6):1133–1144.
   PubMed Web of Science ®Google Scholar
• Corrao G, Parodi A, Nicotra F, et al. Better compliance to antihypertensive medications reduces cardiovascular risk. J Hypertens. 2011;29(3):610–618.
   PubMed Web of Science ®Google Scholar
• Lee H, Yano Y, Cho SMJ, et al. Adherence to antihypertensive medication and incident cardiovascular events in young adults with hypertension. Hypertension. 2021;77(4):1341–1349.
   PubMed Web of Science ®Google Scholar
• Berra E, Azizi M, Capron A, et al. Evaluation of adherence should become an integral part of assessment of patients with apparently treatment-resistant hypertension. Hypertension. 2016;68(2):297–306.
   PubMed Web of Science ®Google Scholar
• Pandey A, Raza F, Velasco A, et al. Comparison of morisky medication adherence scale with therapeutic drug monitoring in apparent treatment-resistant hypertension. J Am Soc Hypertens. 2015;9(6):420–426.e2.
   PubMed Web of Science ®Google Scholar
• Lam WY, Fresco P. Medication adherence measures: An overview. Biomed Res Int. 2015;2015(217047):217047.
   PubMed Web of Science ®Google Scholar
• Williams B, Mancia G, Spiering W, ESC Scientific Document Group, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39(33):3021–3104.
   PubMed Web of Science ®Google Scholar
• Krousel-Wood M, Joyce C, Holt EW, et al. Development and evaluation of a self-report tool to predict low pharmacy refill adherence in elderly patients with uncontrolled hypertension. Pharmacotherapy. 2013;33(8):798–811.
   PubMed Web of Science ®Google Scholar
• Steiner JF, Ho PM, Beaty BL, et al. Sociodemographic and clinical characteristics are not clinically useful predictors of refill adherence in patients with hypertension. Circ Cardiovasc Qual Outcomes. 2009;2(5):451–457.
   PubMed Web of Science ®Google Scholar
• Gao W, Liu H, Ge C, et al. A clinical prediction model of medication adherence in hypertensive patients in a Chinese community hospital in Beijing. Am J Hypertens. 2020;33(11):1038–1046
   PubMed Web of Science ®Google Scholar
• Gupta P, Patel P, Strauch B, et al. Risk factors for nonadherence to antihypertensive treatment. Hypertens (Dallas, Tex 1979). 2017;69(6):1113–1120.
   PubMed Web of Science ®Google Scholar
• Van Der Sande NGC, Blankestijn PJ, Visseren FLJ, et al. Prevalence of potential modifiable factors of hypertension in patients with difficult-to-control hypertension. J Hypertens. 2019;37(2):398–405.
   PubMed Web of Science ®Google Scholar
• De Geest S, Zullig LL, Dunbar-Jacob J, et al. ESPACOMP medication adherence reporting guideline (EMERGE). Ann Intern Med. 2018;169(1):30–35.
   PubMed Web of Science ®Google Scholar
• Lane D, Lawson A, Burns A, et al. Nonadherence in hypertension: How to develop and implement chemical adherence testing. Hypertens (Dallas, Tex 1979). 2021;79(1):12–23.
   Google Scholar
• Punt AM, Stienstra NA, van Kleef MEA, et al. Screening of cardiovascular agents in plasma with LC-MS/MS: a valuable tool for objective drug adherence assessment. J chromatogr B. Anal Technol Biomed Life Sci. 2019;1121:103–110.
   PubMed Web of Science ®Google Scholar
• Lawson AJ, Shipman KE, George S, et al. A novel “dilute-and-Shoot” liquid chromatography-tandem mass spectrometry method for the screening of antihypertensive drugs in urine. J Anal Toxicol. 2016;40(1):17–27.
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Hoes AW, Agewall S, ESC Scientific Document Group, et al. 2016 European guidelines on cardiovascular disease prevention in clinical practice: the sixth joint task force of the European society of cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representat. Eur Heart J. 2016;37(29):2315–2381.
   PubMed Web of Science ®Google Scholar
• Donders ART, van der Heijden GJMG, Stijnen T, et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol. 2006;59(10):1087–1091.
   PubMed Web of Science ®Google Scholar
• Schafer JL. Multiple imputation: a primer. Stat Methods Med Res. 1999; Mar8(1):3–15.
   PubMed Web of Science ®Google Scholar
• Rubin DB. Multiple imputation for survey nonresponse. New York: Wiley; 1987.
   Google Scholar
• Wood AM, Royston P, White IR. The estimation and use of predictions for the assessment of model performance using large samples with multiply imputed data. Biom J. 2015; Jul57(4):614–632.
   PubMed Web of Science ®Google Scholar
• Moons KGM, Altman DG, Reitsma JB, et al. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): explanation and elaboration. Ann Intern Med. 2015;162(1):W1–73.
   PubMed Web of Science ®Google Scholar
• Steyerberg EW. Clinical prediction models. New York, NY: Springer; 2019.
   Google Scholar
• Steyerberg EW, Eijkemans MJ, Harrell FEJ, et al. Prognostic modelling with logistic regression analysis: a comparison of selection and estimation methods in small data sets. Statist Med. 2000;19(8):1059–1079.
   PubMed Web of Science ®Google Scholar
• Pavlou M, Ambler G, Seaman SR, et al. How to develop a more accurate risk prediction model when there are few events. BMJ. 2015;351:h3868.
   PubMed Web of Science ®Google Scholar
• Janssen KJM, Moons KGM, Kalkman CJ, et al. Updating methods improved the performance of a clinical prediction model in new patients. J Clin Epidemiol. 2008;61(1):76–86.
   PubMed Web of Science ®Google Scholar
• Whiting PF, Rutjes AWS, Westwood ME, QUADAS-2 Steering Group, et al. A systematic review classifies sources of bias and variation in diagnostic test accuracy studies. J Clin Epidemiol. 2013;66(10):1093–1104.
   PubMed Web of Science ®Google Scholar
• Alba AC, Agoritsas T, Walsh M, et al. Discrimination and calibration of clinical prediction models: Users’ guides to the medical literature. JAMA. 2017;318(14):1377–1384.
   PubMed Web of Science ®Google Scholar
• Ritscher S, Georges C, Wunder C, et al. Assessment of adherence to diuretics and β-blockers by serum drug monitoring in comparison to urine analysis. Blood Press. 2020;29(5):291–298
   PubMed Web of Science ®Google Scholar
• Ritscher S, Hoyer M, Georges C, et al. Benefit of serum drug monitoring complementing urine analysis to assess adherence to antihypertensive drugs in first-line therapy. PLoS One. 2020;15(8):e0237383.
   PubMed Web of Science ®Google Scholar
• Vergouwe Y, Steyerberg EW, Eijkemans MJC, et al. Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol. 2005;58(5):475–483.
   PubMed Web of Science ®Google Scholar
• Collins GS, Ogundimu EO, Altman DG. Sample size considerations for the external validation of a multivariable prognostic model: a resampling study. Stat Med. 2016; 35(2):214–226.
   PubMed Web of Science ®Google Scholar
• White IR, Carlin JB. Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values. Stat Med. 2010;29(28):2920–2931.
   PubMed Web of Science ®Google Scholar
• van der Laan DM, Elders PJM, Boons CCLM, et al. Factors associated with antihypertensive medication non-adherence: a systematic review. J Hum Hypertens. 2017;31(11):687–694.
   PubMed Web of Science ®Google Scholar
• Meredith PA, Elliott HL. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet. 1992; 22(1):22–31.
   PubMed Web of Science ®Google Scholar
• NHS digital. Prescription Cost Analysis - England, 2018. [PAS] [Internet]. NHS. 2018 [cited 2021 Aug 31]. Available from: https://digital.nhs.uk/data-and-information/publications/statistical/prescription-cost-analysis/2018.
   Google Scholar